Our care and research: At Mark Hinds Optometrists and Ophthalmic Trials Australia (OTA), our team is committed to improving the lives of patients living with severe ocular surface disease through research, innovation, and compassionate clinical care. One area of increasing focus is ocular graft-versus-host disease (oGVHD) — a potentially debilitating complication that can occur following… Continue reading Advancing Care for Patients with Ocular Graft-versus-Host Disease (oGVHD)